The underlying hypothesis is that reduced copy numbers of GSTM1 and GSTT1 lead to reduced enzyme activities, which in turn increases the risk of SIDS and/or decreases the lifespan of SIDS victims. The gene discussed is GSTM1; the disease is sudden infant death syndrome.